论文信息 - Elacridar, a third-generation ABCB1 inhibitor, overcomes resistance to docetaxel in non-small cell lung cancer. - 字舞流文

Elacridar, a third-generation ABCB1 inhibitor, overcomes resistance to docetaxel in non-small cell lung cancer.

Hiromasa Yamamoto | J. Soh | S. Toyooka | S. Miyoshi | K. Tsukuda | Hiroki Sato | S. Tomida | K. Shien | Mototsugu Watanabe | K. Suzawa | K. Namba | Hidejiro Torigoe | Haiyang Chen | Hiroaki Asano | H. Yamamoto | Hiroki Sato